Navigation Links
Biorem Reports 2014 Second Quarter Results
Date:8/22/2014

GUELPH, ON, Aug. 22, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced results for the three month and six month periods ended June 30, 2014.  Biorem's complete 2014 second quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).

Financial Summary:Three-months ended

June 30,

Six-months ended

June 30,( in CDN$'000 except per share data)

2014

2013

2014

2013Revenue

2,459

5,010

4,433

9,195Gross profit

56

1,485

385

2,585Ebitda*

(623)

507

(965)

740Net earnings (loss)

(835)

254

(1,366)

223Basic earnings (loss) per share

Diluted earnings (loss) per share

(0.06)

(0.06)

0.02

 0.01

(0.11)

(0.11)

  0.02

  0.01*Earnings before interest, taxes and amortization, a non IFRS financial measure 

Revenues for the quarter totaled $2,459,000, a 25% increase over revenues of $1,974,000 recorded during the first quarter of 2014 and a $2,550,000 or 51% decrease over revenues recorded during the second quarter of 2013. Year to date revenues have declined 52% to $4,433,000 compared to $9,195,000 in the same period in the prior year.  

Gross profit for the quarter was 2.2% of revenue compared to 16.7% for the quarter ended March 31, 2014 and 26.9% for the quarter ended June 30, 2013. Gross profit for the quarter was negatively impacted during the quarter by the one-time provision for loss that was recorded against a project that requires remedial work. In the absence of this provision for loss, gross profit for the quarter would have been $656,000 or 23.7 % of revenue which is consistent with the gross profit percentage achieved in previous quarters.

For the six month period gross profit decreased by $2,200,000, an 85% decrease from the gross profit of $2,585,000 recorded for the six months ended June 30, 2013.

Operating expenses in the quarter of $748,000 were 31% lower than the $1,088,000 of expenses recorded in the same period in the previous year. For the six months ended June 30, 2014 operating expenses were $1,482,000, a 29% decrease over operating expenses of $2,073,000 in the comparable period in 2013.
The decrease in operating expenses were largely the result of  lower sales commissions earned on the lower revenue recorded,  and by lower general and administrative costs and lower expenditures on research and development resulting from cost reductions initiated by the Company.

Net loss for the quarter and six months ended were $835,000, and $1,366,000 respectively compared to earnings of $254,000 and $223,000 in 2013.  On a loss per share basis loss for the quarter was $0.06 per share and $0.11 per share for the six month period ended June 30, 2014.

"We had expected the quarter to be soft since orders had slowed in the latter half of 2013. However orders are picking up along with evidence that the overall market conditions have improved significantly as evidenced by the growth in our backlog," said Peter Bruijns, President & CEO. "Biorem experienced a technology challenge on one project which required a significant cost allocation to ensure technical performance and this substantially affected our gross margin. The margin reduction resulting from this allocation is not an indication that average margins are under pressure."

The Company succeeded in booking new orders totalling $3.8 million in the Quarter which resulted in an order backlog at the end of June 2014 of $9.7 million.

About BIOREM Inc.
Biorem is a leading clean technology company that designs, manufactures and distributes a comprehensive line of high-efficiency air emissions control systems used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). With sales and manufacturing offices across the continent, a dedicated research facility, a worldwide sales representative network and more than 800 installed systems worldwide, Biorem offers state-of-the-art technology-based products and peace of mind for municipalities, industrial companies and their surrounding communities. Additional information on Biorem is available on our website at www.biorem.biz.


'/>"/>
SOURCE Biorem Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. DryLet to Attend UpTech Upstream Oil and Gas Summit on October 6-8, 2013 in Alberta to Showcase MB Bioremediation
2. DryLet Technologies Announces Website Launch and New Logo Design for Patented MB Bioremediation
3. Altogen Labs Announces Patent Filing for Bioremediation Process and Oil Spill Cleanup Products
4. Diabetes Drugs Industry Growth Analysis in Global, China Regions Research Report Available at DeepResearchReports.com
5. Internationals Seaweed Fertilizer Industry 2014 Development Trend Analysis in New Research Study at DeepResearchReports.com
6. Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com
7. Dyadic International Reports Q2 2014 Financial Results
8. Sinovac Reports Unaudited Second Quarter Financial Results
9. Pressure BioSciences, Inc. Reports Second Quarter 2014 Financial Results and Provides Business Update
10. RXi Pharmaceuticals Reports Financial Results for the Second Quarter of 2014
11. Synthetic Biologics Reports Second Quarter 2014 Financial Results and Operational Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... Florida , February 11, 2016 ... and Promote Genetic Understanding to Support Research and Discovery ... GenomeAsia 100K, today announced an ambitious plan to sequence 100,000 ... South Asian countries and at least 7 of North and ... In the first phase, the project will focus on ...
(Date:2/11/2016)... Feb. 11, 2016  Bioethics International, a not-for-profit organization focused ... developed, marketed and made accessible to patients around the world, ... had named the publication of the Good Pharma Scorecard ... is also featured as one of BMJ Open ,s ... year that are most frequently read. Ed Sucksmith ...
(Date:2/11/2016)... , Feb. 11, 2016  Dovetail Genomics™ LLC today ... beta program for a planned metagenomic genome assembly service. ... company,s metagenomic genome assembly method in a talk on ... Biology & Technology conference in Orlando, Fla. ... highly complex datasets is difficult. Using its proprietary ...
(Date:2/11/2016)... ... 2016 , ... Global Stem Cells Group, a ... Stem Cells Network (GSCN) to distribute exosome injection and other biological products to ... Rica, Dominican Republic, Colombia, Argentina, Nicaragua, Panama, El Salvador, Venezuela, Peru, Ecuador, Paraguay, ...
Breaking Biology Technology:
(Date:2/2/2016)... 2016  BioMEMS devices deployed in hospitals ... medical screening and diagnostic applications, such as ... that facilitate and assure continuous monitoring without ... being bolstered through new opportunities offered by ... coupled with wireless connectivity and low power ...
(Date:2/2/2016)... 2016 Technology Enhancements Accelerate Growth of X-ray Imaging ... digital and computed radiography markets in Thailand ... Indonesia (TIM). It provides an in-depth ... well as regional market drivers and restraints. The study ... and market attractiveness, both for digital and computed radiography. ...
(Date:2/1/2016)... Canada , February 1, 2016 ... technological advancements to drive global touchfree intuitive gesture control ... --> Rising sales of consumer electronics coupled ... gesture control market size through ... consumer electronics coupled with new technological advancements to drive ...
Breaking Biology News(10 mins):